Mycoplasma test

About this test

What This Test Measures

The test detects IgG and IgM antibodies against Mycoplasma pneumoniae.

Mycoplasma pneumoniae IgM antibodies
IgM antibodies are typically linked to the early phase of the immune response and may support interpretation of more recent exposure to Mycoplasma pneumoniae. However, antibody timing can vary, and early infection may not always produce detectable antibody levels.

Mycoplasma pneumoniae IgG antibodies
IgG antibodies usually develop later in the immune response and may remain detectable after exposure. A positive IgG result may support interpretation of previous exposure or an established immune response to Mycoplasma pneumoniae, but it does not confirm active infection on its own.

This test provides a qualitative result, meaning it indicates whether antibodies were detected or not detected. It does not provide a quantitative antibody level.

Target Audience

This test is intended for healthcare professionals who need a rapid Mycoplasma pneumoniae IgG and IgM antibody screening tool for use within healthcare settings.

How It Works

1. Order the Kit
The kit is ordered for professional use in healthcare settings.

2. Collect the Sample
A blood sample is collected according to the included instructions.

3. Run the Test
The sample and buffer are applied to the test cassette according to the test procedure.

4. Read the Result
The result is read after 10 minutes. Results should not be interpreted after 20 minutes.

Sample Collection

The test uses a finger prick blood sample. The sample is collected from the fingertip and applied to the test cassette together with the included buffer, according to the test procedure.

Sample collection, handling and result interpretation should be performed according to the included instructions and applicable professional procedures.

Preparation Before Testing

Bring the test, sample, buffer and any controls to room temperature 15 to 30 °C before use.

Follow the included test instructions for sample collection, timing and result interpretation. Testing should be performed by healthcare professionals within the appropriate healthcare setting.

Symptoms and Clinical Context

Mycoplasma pneumoniae infection may be associated with respiratory symptoms such as persistent dry cough, fever, headache, fatigue, sore throat and muscle aches.

Clinical presentation can vary from mild respiratory illness to pneumonia like symptoms. Because symptoms can overlap with other respiratory infections, antibody results should be interpreted together with timing of illness, symptoms, patient history and other relevant clinical findings.

Important Limitations

This test is intended as a screening tool and provides qualitative detection of IgG and IgM antibodies against Mycoplasma pneumoniae. It does not provide a quantitative antibody level.

A negative result does not exclude Mycoplasma pneumoniae infection, especially during the window period or if antibody levels are below the detectable limit of the test.

Results should not be used as the only basis for diagnosis or treatment decisions. A confirmed diagnosis and treatment decision should be made by a physician after evaluation of clinical findings and relevant laboratory information.

Biomarkers included

• IgG antibodies to Mycoplasma pneumoniae: IgG antibodies are produced later in the immune response and usually reflect past exposure to Mycoplasma pneumoniae. They tend to appear 2–3 weeks after infection onset and can remain detectable for months or years. A positive IgG result does not necessarily indicate an active infection but shows that the immune system has previously encountered the pathogen. In combination with IgM, IgG testing h
• IgM antibodies to Mycoplasma pneumoniae: IgM antibodies are the first type of antibodies produced by the immune system in response to an acute infection. When IgM against Mycoplasma pneumoniae is present, it typically indicates a recent or ongoing infection. These antibodies appear within 1–2 weeks of exposure and usually decline after a few months. Testing for IgM is useful in identifying the early phase of a Mycoplasma pneumoniae infec

How to prepare

Bring the test, sample, buffer and any controls to room temperature 15 to 30 °C before use. Follow the included test instructions and applicable professional procedures for sample collection, timing and result interpretation.

Frequently asked questions

What is the difference between IgG and IgM antibodies?

IgM may be associated with an earlier immune response, while IgG usually develops later and may remain detectable after exposure. Interpretation depends on clinical context and timing.

Can a negative result exclude Mycoplasma pneumoniae infection?

No. A negative result does not exclude infection, especially during the window period or if antibody levels are below the detectable limit of the test.

Is this test intended for home use?

No. The test is CE-marked and intended for professional use in healthcare settings.

Customer reviews

5.0/5 (3)

• 5/5 — Discrete packaging was appreciated and it was very easy to use.
• 5/5 — Glad I could do this at home. Fast results!
• 5/5 — Clear instructions and the sample collection was much easier than I expected.